Vaylenx Overview

  • Founded
  • 2015
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Vaylenx General Information


Operator of a biotechnology firm intended to develop vector control methods and services that are environment-friendly. The company's services include developing modern expertise to fight against mosquito-spread diseases that will effectively slow the spread of widespread mosquito-spread disease, enabling users with ecological and cost-effective chemical products to prevent deadly mosquito-borne diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Consumer Durables
Primary Office
  • 1741 West Melrose
  • CH-2
  • Chicago, IL 60657
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vaylenx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business Completed Out of Business
3. Early Stage VC Completed Generating Revenue
2. Grant 25-Apr-2016 $5K Completed Generating Revenue
1. Grant 01-Jan-2016 $10K Completed Generating Revenue
To view Vaylenx’s complete valuation and funding history, request access »